Form 8-K BOSTON SCIENTIFIC CORP For: Jul 28

Go back to Form 8-K BOSTON SCIENTIFIC CORP For: Jul 28

Boston Scientific (BSX) PT Raised to $28 at Needham & Company

July 28, 2016 2:38 PM EDT

Needham & Company analyst Mike Matson reiterated a Buy rating and bumped his price target on Boston Scientific (NYSE: BSX) to $28.00 (from $26.00) following doubled-digit organic growth in Q2.

Matson commented, "BSX beat consensus 2Q16 revenue and met consensus EPS. BSX's organic constant currency... More